Tin tức & Cập nhật
Lọc theo Chuyên ngành:

Rivaroxaban a game-changer for acute LV thrombus post-MI
15 May 2025
bởiElvira Manzano
Patients who develop an acute thrombus in the left ventricle (LV) following myocardial infarction (MI) fare equally well when treated with rivaroxaban as they do with warfarin, as shown in the RIVAWAR study.
Rivaroxaban a game-changer for acute LV thrombus post-MI
15 May 2025
EGFR-related skin AE rates drop with COCOON regimen
14 May 2025
bởiAudrey Abella
Interim data from the phase II COCOON trial demonstrate the potential of the COCOON dermatologic management (DM) regimen to significantly reduce the incidence and severity of dermatologic adverse events (dAEs) tied to amivantamab plus lazertinib treatment in patients with EGFR-mutant (EGFRm) non-small cell lung cancer (NSCLC).